Cobactan 2.5% 100 ml (single pack)
For the treatment of bacterial infections in cattle and pigs caused by the Gram positive and Gram negative microorganisms sensitive to cefquinome:CattleRespiratory disease caused by Pasteurella multocida and Mannheimia haemolytica.Digital dermatitis, infectious bulbar necrosis and acute interdigital... Read more
For the treatment of bacterial infections in cattle and pigs caused by the Gram positive and Gram negative microorganisms sensitive to cefquinome:
Cattle
Respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica.
Digital dermatitis, infectious bulbar necrosis and acute interdigital necrobacillosis (foul in the foot).
Acute E. coli mastitis with signs of systemic involvement.
Calves
E. coli septicaemia in calves.
Pigs
For the treatment of bacterial infections of the lungs and respiratory tract caused by Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae, Streptococcus suis and other cefquinome-sensitive organisms.
Mastitis-Metritis-Agalactia Syndrome (MMA) with involvement of E. coli, Staphylococcus ssp., Streptococcus spp. and other cefquinome-sensitive organisms.
Piglets
Reduction of mortality in cases of meningitis caused by Streptococcus suis.
For the treatment of:
Arthritis caused by Streptococcus spp., E. coli and other cefquinome-sensitive organisms.
Epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.
Visit www.myvetmeds.co.uk / farm / pig-farm / antibiotics-pig / cobactan-2-5-100-ml.htm
Product Description
About Cobactan 2.5% 100 ml (single pack)
For the treatment of bacterial infections in cattle and pigs caused by the Gram positive and Gram negative microorganisms sensitive to cefquinome:
Cattle
Respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica.
Digital dermatitis, infectious bulbar necrosis and acute interdigital necrobacillosis (foul in the foot).
Acute E. coli mastitis with signs of systemic involvement.
Calves
E. coli septicaemia in calves.
Pigs
For the treatment of bacterial infections of the lungs and respiratory tract caused by Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae, Streptococcus suis and other cefquinome-sensitive organisms.
Mastitis-Metritis-Agalactia Syndrome (MMA) with involvement of E. coli, Staphylococcus ssp., Streptococcus spp. and other cefquinome-sensitive organisms.
Piglets
Reduction of mortality in cases of meningitis caused by Streptococcus suis.
For the treatment of:
Arthritis caused by Streptococcus spp., E. coli and other cefquinome-sensitive organisms.
Epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
See dosage table. At
http://www.noahcompendium.co.uk/Intervet_Schering-Plough/documents/S4376.html
All treatments to be given by intramuscular injection. Studies have indicated the advisability of giving second and subsequent injections at a different injection site. The preferred injection site is in muscular tissue of the mid-neck region.
To ensure correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
Shake the vial well before using.
The veterinary medicinal product does not contain an antimicrobial preservative. Swab the septum before removing each dose. Use a dry sterile needle and syringe. An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes, for example when treating piglets.
The cap may be safely punctured up to 25 times. The 50ml vial should be used for treating small piglets. When treating groups of animals, use a draw-off needle.
Active Ingredient
Cobactan 2.5% 100 ml (single pack) ingredients
Suspension for injection.
Each ml contains:
Cefquinome (as sulfate) 25 mg
Side Effects
Side effects of Cobactan 2.5% 100 ml (single pack)
Do not use Cobactan 2.5% in animals which are known to be hypersensitive to ?-lactam antibiotics.
Do not administer to animals less than 1.25 kg body weight.
Use of the veterinary medicinal product should be based on susceptibility testing and take into account official and local antimicrobial policies.
The use of cefquinome should be restricted to appropriate use according to the labelled indications in the target animal species.
Inappropriate use of the product may increase the prevalence of bacteria resistant to cefquinome and may decrease the effectiveness of treatment with other beta lactam antibiotics, due to the potential for cross resistance.
Narrow spectrum antibacterial therapy should be used for first line treatment where susceptibility testing suggests the likely efficacy of this approach.
Use of the veterinary medicinal product may result in localized tissue reaction. Tissue lesions should resolve 15 days after the last administration of the veterinary medicinal product.
Hypersensitivity reactions to cephalosporins occur rarely.
There is no available information indicating reproductive toxicity in cattle or pigs. In reproduction toxicity studies in laboratory animals cefquinome did not reveal any effect on reproduction or teratogenic potential.
Use only according to the benefit/risk assessment of the responsible veterinary surgeon.
It is known that a cross-sensitivity to cephalosporin exists for bacteria sensitive to the cephalosporin group.
Due to undesirable pharmacodynamic interaction, do not apply cefquinome simultaneously with pharmaceuticals acting bacteriostatically.
Overdoses of 20 mg/kg/day in cattle and 10 mg/kg/day in pigs have been well tolerated.
Additional Data
Cobactan 2.5% 100 ml (single pack) specification
| Specification: | Detail: |
|---|---|
| Pack Size: | single pack |
| Brands: | Intervet |
| Product Form: | injection |
| External Link: | http://www.noahcompendium.co.uk/Intervet_Schering-Plough/documents/S4376.html |
| Strength/Size: | 2.5% 100 ml |
